| Diabetes (666) |  |
| Dwarfism (7) | |
once embedded under the skin monitors substances in the blood such as glucose and cholesterol so that chronic diseases like diabetes or the effects of treatments such as chemotherapy can be monitored.
People who have a mental disorder have a much higher rate of diabetes for example. They also have changes in their immune system.
lungs and kidneys and induce diabetes, high blood pressure and cardiovascular disease. Partial solutions exist for the filtering out of arsenic
The technology could also be applied to medicine, for example, to continuously monitor diabetics or cystic fibrosis sufferers.
north of London, is being used for sufferers of cardiovascular diseases, diabetes or obesity. The device, worn on the waist, can take measurements 24 hours a day,
Diets rich in fruit and vegetables have been linked to important health outcomes including reductions in cardiovascular disease type 2 diabetes and some forms of cancer.
or two fist-size servings of these nonstarchy vegetables reduced their risk for liver problems Type 2 diabetes and other complications of obesity.
#Diabetes may raise risk for heart valve disease Rice university right Original Studyposted by Mike Williams-Rice on October 21 2014 There appears to be a link between high blood sugar and heart valve hardening.
That results in patients with diabetes having problems with vision and with their nerves and kidneys as well.
The results that high glucose concentration can also cause pathologic remodeling by the aortic-valve cells could suggest that diabetes is also directly a cause of aortic-valve disease he adds.
which can lead to type 2 diabetes. It s not as common as the link between atherosclerosis and diabetes but it s definitely an appreciable strong subset.
To understand any heart valve-related disease we need to understand the mechanism of how the cells interact with excess lipids
These mutations cause more than 200 diseases and contribute to others such as diabetes, cancer, Parkinson disease,
#Drug for parasitic worms fights diabetes in mice Rutgers rightoriginal Studyposted by Rob Forman-Rutgers on October 7 2014a modified form of a drug commonly used to eliminate intestinal parasites may hold the key to battling type
2 diabetes at its source. The Centers for Disease Control and Prevention projects that 40 percent of all Americans now alive will develop type 2 diabetes.
Type 2 is the form of diabetes once known as##adult onset##in which the body produces insulin that ordinarily would keep blood sugar under control
but either it does not produce enough insulin or the body s ability to use that insulin is degraded.
and ultimately reverse the diabetes entirely. That outcome is far from certain but Jin says the positive changes he saw in the mice are encouraging.
people of normal weight can develop fatty livers and type 2 diabetes. This kind of medication if shown to be effective could safely treat patients of all weights.
##The National Institute of Diabetes and Digestive and Kidney Disorders the National Institute of Arthritis and Musculoskeletal and Skin diseases China s National Science Fund for Distinguished Young Scientists and Merck
#Why a deadly drug didn t hurt lab rat livers Scientists believe they ve solved the mystery of why a diabetes drug introduced in 1997 caused fatal liver failure in 63 patients.
In 1997 troglitazone was approved for use in the United states as one of the first drugs designed to treat type 2 diabetes.
Patients could use this device in a way that's very similar to how diabetics use glucose-monitoring devices
A patient sticks a finger with a lance similar to those used by diabetics to produce a droplet of blood.
and excisions in diabetic rats in studies that are now under way. Researchers from Johns Hopkins and the National Institute on Alcohol abuse and Alcoholism participated in the study.
#Glucose control switch links both types of diabetes Scientists have linked a mechanism in the brain that senses glucose levels in the blood
and kick starts the body insulin response to both type 1 and type 2 diabetes. ee discovered that the prolyl endopeptidase enzymeocated in a part of the hypothalamus known as the ventromedial nucleusets a series of steps
and lead author Sabrina Diano. ur findings could eventually lead to new treatments for diabetes.
and became diabetic. Diano, a professor in the departments of obstetrics, gynecology, and reproductive sciences,
preventing diabetes. The findings are published in the Proceedings of the National Academies of Sciences. ecause of the low levels of endopeptidase,
and the mice developed diabetes. says Diano, who is also a member of the Yale Program in Integrative Cell Signaling and Neurobiology of Metabolism.
and treat type 2 diabetes, she says. The National institutes of health, and the American Diabetes Association supported the research
#See into living brain with lasers and nanotubes By injecting carbon nanotubes into the bloodstream, scientists can use near-infrared lasers to see blood flow in a living animal brain.
#Wearable vapor sensor can smell diabetes A wearable vapor sensor could monitor diseases such as diabetes
says Sherman Fan, professor of biomedical engineering at University of Michigan. or diabetes, acetone is a marker, for example.
and chronic diseases such as hypertension and diabetes. The researchers conducted experiments to gauge the effect of insufficient sleep on memory.
An increase in diabetes likely acted in the opposite direction, however, pushing stroke rates back up to some extent.
#Drug cocktail might help diabetics make insulin Combining two different medications could help patients with Type 1 diabetes at least partially regain the ability to produce their own insulin.
Haller treated 17 adult Type 1 diabetes patients for two weeks with the cocktail therapy and then followed them for a year.
Haller presented his findings this month at the annual meeting of the American Diabetes Association in San francisco. PROFOUND RESULTS Conventional diabetes wisdom says that within just a few months of the onset of Type 1 diabetes,
That the treatment seemed to stimulate insulin production in people with established Type 1 diabetes made the researchers autiously optimistic,
The patients in Haller study had been living with Type 1 diabetes between four months and two years. he model has mostly been to test therapies aimed at beta cell preservation in people who have just been diagnosed,
COMBINATION THERAPIES Atkinson began considering Thymoglobulin as a treatment for diabetes nearly a decade ago.
He and fellow co-investigator Desmond Schatz, associate chairman of the department of pediatrics, authored a paper advocating a combination approach to treating Type 1 diabetes.
1 diabetes we are as yet unable to cure and prevent the disease, Schatz says. his study is a step in that direction, toward a biological cure.
the study could potentially be paradigm-shifting for our field in that it documents we should really be looking at combination therapies in treating Type 1 diabetes,
This study is an important step forward in our efforts to make life easier for patients with Type 1 diabetes. k
The device controls blood sugar in patients with type 1 diabetes using doses of both insulin
The adolescent trial enrolled 32 participants, ages 12 to 20, attending a camp for young people with type 1 diabetes,
OT HAVING TO THINK ABOUT DIABETES 24/7damiano, whose 15-year-old son was diagnosed with type 1 diabetes at the age of 11 months,
explains what having a device like this could mean to patients. he most practical difference would be not having to think about diabetes 24/7,
not having to constantly make decisions about things that those of us without type 1 never have to think about. nother real problem that would be relieved is the fearear of going to bed at night
but still had significant episodes of hypoglycemia. nd another extremely frustrating aspect of diabetes that would be eliminated completely by this device is the enormous sense of failure
and provide a bridge to the often-promised but still elusive cure for type 1 diabetes.
/The National Institute of Diabetes and Digestive and Kidney diseases, the Helmsley Charitable trust, and the Charlton Fund for Innovative Research in Diabetes supported the study.
Several members of the research team have been issues or applied for patents related to the development of the bionic pancreas.
Another Star-developed chip measures acetone in breath, an indicator of diabetes. A National Energy technology Laboratory grant supported the research
#Gastric banding treats diabetes in overweight people Gastric banding can play a vital role in the treatment of type 2 diabetes in people who are overweightot just those who are obese.
Monash University researchers found that weight loss surgery (gastric banding) for overweight people with diabetes had a profound impact on the illness. his is randomized the first controlled trial demonstrating that treatment of type 2 diabetes
this study indicates a potentially attractive path for the overweight person with diabetes and for those providing the care.
The study, published in the Lancet Diabetes and Endocrinology, looked at people who suffered diabetes
The connection between excessive body weight and diabetes is well known, but while the benefits of weight loss for obese people suffering type 2 diabetes have been well document,
it has not been clear if those who were overweight would enjoy the same benefits.
The study enrolled 50 people with diabetes who were overweight but not obese, with a body mass index between 25 and 30. e provided a comprehensive program of multidisciplinary care to all of the participants,
more than half of the banded group were in remission of their diabetes while only eight percent of the non banded group were in remission.
The results showed a strong relationship between the amount of weight loss and remission of diabetes
clearly showing that successful ways of reducing weight such as gastric banding should have a high priority in the treatment of diabetes e
#Math that predicts glucose paves way for artificial pancreas A mathematical model can predict with more than 90 percent accuracy the blood glucose levels of individuals with type 1 diabetes up to 30 minutes before a change
in levels. any people with type 1 diabetes use continuous glucose monitors, which examine the fluid underneath the skin,
The team tested the accuracy of its model using an FDA-approved UVA/Padova simulator with 30 virtual patients and five living patients with type 1 diabetes.
The results appeared online in the Journal of Diabetes Science and Technology. DYNAMIC DEPENDENCIES e learned that the dynamic dependencies of blood glucose on insulin dose
Diets rich in fruit and vegetables have been linked to important health outcomes including reductions in cardiovascular disease type 2 diabetes and some forms of cancer.
#Wearable vapor sensor can smell diabetes University of Michigan rightoriginal Studyposted by Catharine June-U. Michigan on August 6 2014.
A wearable vapor sensor could monitor diseases such as diabetes and hypertension by picking up airborne biomarkers exhaled
. or diabetes acetone is a marker for example. ther biomarkers it could detect include nitric oxide and oxygen abnormal levels
when diabetics, wounded veterans, or older people are prone to lose their sight. The Braille studies will be presented in Seattle this September at the 18th International Symposium on Wearable computers (ISWC.
The discovery has implications for understanding age-related diseases including cancers, neurodegenerative disorders and diabetes.##One way all mammalian cells produce energy is via aerobic respiration, in
which can lead to conditions such as Alzheimer s disease and diabetes. To investigate why this decline occurs,
The electrode could even be used to simulate sugary treats for people with diabetes. In fact this same research team is also working on a digital lollipop:
#Bionic pancreas shows promise in managing diabetes The bionic pancreas In 2000, Ed Damiano s son was diagnosed with type 1 diabetes.#
Type 1 diabetes occurs when beta islet cells in the pancreas die off. These cells sense levels of blood sugar, aka glucose,
Damiano, who works at the University of Boston, says a bionic pancreas his team has developed with colleagues at the Massachusetts General Hospital offers hope of a normal life to people with type 1 diabetes.
A smartphone-linkedpancreas removes the need for people with type 1 diabetes to constantly monitor
were monitored also for five days at a summer camp for kids with diabetes. For both groups, the results with the bionic pancreas were compared with five days of the participants using their usual method of controlling the disease pricking their finger to monitor glucose levels
what the participants were able to do managing their own diabetes prior to the trial, he says.
the longer you can stave off the long-term health complications of diabetes, says Damiano. Emotional impact The study had a tremendous emotional impact on participants.
They got a glimpse of life without diabetes and that is pretty profound, he says. In many cases, the participants were reluctant to give the devices back,
both in the US and in the UK, says Alasdair Rankin, director of research at Diabetes UK,
but there is now real hope that this technology has the potential to transform the lives of people with type 1 diabetes within a generation,
The results of Damiano s study and several other groups working on artificial pancreases were presented today at the meeting of the American Diabetes Association in San francisco. Via New Scientist Share Thissubscribedel. icio
#Researchers discover new treatment for diabetes Researchers discovered a small molecule that inhibits an enzyme that degrades insulin.
and treat diabetes after decades of searching. They have discovered a whole different method for maintaining insulin in the blood:
and helps regulate the body response to sugars process that goes awry in type 2 diabetes.
Genetic studies have shown that people with type 2 diabetes are more likely to have mutations in the gene that encodes a protein called insulin-degrading enzyme, or IDE.
Patients with type 2 diabetes either have an insufficient amount of insulin in their blood
Researchers have speculated for decades that a drug that could inhibit IDE might help some type 2 diabetes patients.
The newly identified IDE inhibitor could be the starting point for developing a powerful new drug for type 2 diabetes.
one recent study suggested that the cells may be able to kick-start insulin-making in pancreas in Type-1 diabetics by replacing Beta cells.
#For stem cells in 30 minutes just add acid Embryonic stem cells have huge potential in treating everything from cancer to diabetes because of their ability to morph into almost any other type of cell within the human body.
potentially leading to new regenerative treatments for diseases such as diabetes and Alzheimer s z
#Nanomaterial rivals hardness of diamond An article by Scientific American. It s only a matter of time before a movie villain pulling off the crime of the century needs a cutting tool that is harder than anything else On earth.
saying that work on embryonic-stem-cell lines could lead to therapies for Parkinson s disease, diabetes and other ailments."
In 2008 and 2010, the Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial challenged dogma
Biomedical Research, the UCSF Diabetes Center Obesity Pilot program, and the National institutes of health b
#New ALS Gene and Signaling Pathways Identified Using advanced DNA sequencing methods, researchers have identified a new gene that is associated with sporadic amyotrophic lateral sclerosis (ALS),
This work was supported by grants from the National Institute of Neurological disorders and Stroke (NS070024), the National Institute of Diabetes and Digestive and Kidney diseases (DK054214
Imagine someone being treated for diabetes. You want to make sure they have the right medication. n an interconnected world where smartphones
asthma and diabetes can be all be detected in the breath. Using light to smell might be a little counterintuitive,
whether viral infections can trigger diabetes or chronic fatigue syndrome. Elledge and colleagues used Virscan on more than 500 people from the United states
While IBD is the focus of the initial flagship project the center is designed to foster opportunities to explore the impact of the microbiome on systemic autoimmune diseases such as multiple sclerosis Type 1 diabetes arthritis and other disorders such as
Broad investigators have led international consortia that have found thousands of genetic variants responsible for common diseases such as diabetes heart disease
In contrast to researchers studying cancer or diabetes researchers studying psychiatric disorders have been unable to identify animal models that correctly capture important biological aspects of the disorders
and learn more about diseases of endothelial tissue such as atherosclerosis and diabetic retinopathy, which can cause blindness. ndothelial cells play a very important role in multiple steps of many diseases, from initiation to the onset of clinical complications,
What s happening in a tumor This type of sensor could also be useful for monitoring blood flow in diabetic patients who often experience restricted circulation in their extremities
or diabetes in living systems. his new technique gives us an unprecedented ability to recognize any target molecule by screening nanotube-polymer complexes to create synthetic analogs to antibody function,
They found many patients suffering from chronic diseases such as diabetes, cancer, and heart disease and a lack of permanent oatingsfor medical implants that might help these patients.
#Decoding sugar addiction Together, obesity and Type 2 diabetes rank among our nation greatest health problem,
for example, diabetes, cancer, multiple sclerosis, and osteoporosis. Now Microchips Biotech will begin co-developing microchips with Teva Pharmaceutical, the world largest producer of generic drugs,
"A subcutaneous sensor could save diabetes patients from having to constantly prick their fingers"thinks Ensinger.
Gu has led other research that#has yielded a bio-inspired cocoon that tricks cells into consuming anticancer drugs and an injectable nanonetwork that controls blood sugar levels in diabetics.
and particles in the air and enzymes molecules and antibodies in the body that could indicate diabetes cancer and other diseases.
#Nanotechnology takes on diabetes A sensor which can be used to screen for diabetes in resource-poor settings has been developed by researchers
and tested in diabetic patients, and will soon be tested field in Sub-saharan africa. A low-cost, reusable sensor which uses nanotechnology to screen for
and monitor diabetes and other conditions, has been developed by an interdisciplinary team of researchers from the University of Cambridge, for use both in clinics and home settings.
The sensors use nanotechnology to monitor levels of glucose, lactate and fructose in individuals with diabetes or urinary tract infections
and change colour when levels reach a certain concentration. They can be used to test compounds in samples such as urine, blood, saliva or tear fluid.
Earlier this year, clinical trials of the sensors were carried out at Addenbrooke's Hospital to monitor glucose levels in 33 diabetic patients.
According to the International Diabetes Federation, there are an estimated 175 million undiagnosed diabetic patients worldwide, 80%of
"These sensors can be used to screen for diabetes in resource-poor countries, where disposable test strips and other equipment are simply not affordable,
The researchers are developing a prototype smartphone-based test suitable for both clinical and home testing of diabetes and other clinically relevant conditions."
and adopted as a diagnostic tool for routine diabetes screening, "said Yunuen Montelongo who co-authored the article e
or DNA sequence from one animal into the genome of another plays a critical role in a wide range of medical researchncluding cancer, Alzheimer's disease, and diabetes.
#Wii Fit Plus Helps Diabetics Control Blood sugar As you might already know playing Wii Fit is a funny thing.
In a randomized controlled trial older adults with type 2 diabetes had better controlled blood sugar after playing Wii Fit Plus for half an hour a day every day for 12 weeks.
Their blood sugar#level#reductions were on par with study participants who received the â##standard careâ#doctors normally give people with diabetes the U k. s National Health service reports.
This is encouraging because getting set up to play Wii Fit Plus is cheaper than other forms of diabetes care National Health service reports.
The bottom line is that there s evidence playing Wii Fit Plus daily can help those with type 2 diabetes though it s not exactly a proven treatment yet.
or one on diabetes or obesity it would fit but not here. How can you put up this graph
A robotic learning coach for kids with type 1 diabetes Less than three campaign days left!
Back Sproutel#sâ crowdfunding campaignâ to help get robotic healthcare coach Jerry the Bear into the hands of kids with type 1 diabetes.
Jerry the Bear is a robotic learning coach for children diagnosed with type 1 diabetes (T1d) that helps them master their medical procedures all through play!
The first bears distributed from our campaign will fulfill a queue of families that have submitted already hardship applications to the Type 1 Diabetes Network.
Android developer hacker hustler and resident diabetes expert if our bears ever become sentient you#ll know whom to blame.
and to actually displaying information about your health from your cholesterol levels to indicators for diabetes.
which are substances that have been linked with diabetes and other diseases. The mirror can also assess nutrition and physical activity.
autoimmune disorders, Alzheimer's and diabetes. This patented technology will allow pharmaceutical companies to measure simultaneously a large number of compounds
#More effective drugs for diabetes in the offing Scientists have found a new way to lower blood sugar levels by reducing glucose production in the liver,
paving the way for more effective drugs for type 2 diabetes. Some treatments for type 2 diabetes make the body more sensitive to insulin,
the hormone that lowers blood sugar. But new research at Washington University School of medicine in St louis suggests a different strategy:
They did so by shutting down a liver protein involved in making glucose, an approach that may work in patients with type 2 diabetes."
"We think this strategy could lead to more effective drugs for type 2 diabetes, "said principal investigator Brian N Finck, associate professor of medicine in the Division of Geriatrics and Nutritional Science."
"A drug that shuts down glucose production has the potential to help millions of people affected by the most common form of diabetes,
and the biopharmaceutical company Metabolic Solutions Development Co. The company is involved in clinical trials that are evaluating the drug compound MSDC-0602 as a treatment for diabetes.
In addition to diabetes, the researchers also think that interfering with pyruvate transport may help patients with nonalcoholic fatty liver disease, a condition common in people with obesity y
But the Respitetm nebulizer also has the potential to be used to administer insulin to people with diabetes
To promote angiogenesis in body parts where blood flow is poor due to diabetes, research has been conducted to develop materials that absorb growth factors
to target legs of diabetes patients with poor blood flow and to effectively regenerate blood vessels.
explains that this novel signaling mechanism produces sufficient change in current to be measured using inexpensive electronics similar to those in the home glucose test meter used by diabetics to check their blood sugar.
type 1 diabetes and viral infections as well as facilitating research into T-cell function.''Genome editing in human T-cells has been a notable challenge for the field,
as healthcare increasingly moves from hospitals to patient homes with the advent of technology like home diabetes tests. perfect storm in healthcare is happening,
as healthcare increasingly moves from hospitals to patient homes with the advent of technology like home diabetes tests. perfect storm in healthcare is happening,
#Researchers Uncover New Pathways for Diabetes Research A new Florida State university study is changing how scientists look at diabetes research
including hyperinsulinemia and diabetes. n principle, our findings could open the door for a new approach to treat diseases of glucose homeostasis, such as diabetes,
Miller said. The enzyme is called glucokinase and serves as the body primary glucose sensor as it relays signals in the pancreas
a person often suffers from diabetes, or other glucose-related illnesses. Because of its role in the cell, glucokinase has received considerable attention by pharmaceutical companies as a potential therapeutic target.
which offered hope for treating type 2 diabetes. The focus, however, was on only one way that the enzyme was activated.
According to the American Diabetes Association, 29.1 million Americans have diabetes and case numbers are expected to rise.
There have been some complications with diabetes drugs that activate glucokinase. As a result, some companies have started looking at other options to treat the disease,
the Swedish Research Council, the Strategic Research Program for Diabetes funding at Karolinska Institutet, Stockholm County, the Jane & Aatos Erkko Foundation, the Instrumentarium Science Foundation,
such as hypertension and diabetes, Wang said. rowing evidence suggests intracranial vascular pathology also may be associated with the origin and progression of cerebrovascular disorders and neurodegenerative diseases, such as Alzheimer disease,
people at higher risk of developing the disease include those with a family history of pancreatic cancer, heavy smokers, the obese and people over 50 years with new-onset diabetes.
#Superfast blood tests devised in Montreal could revolutionize diagnosing A simple and fast chemical process developed by scientists in Montreal could allow family doctors to one day use equipment as straightforward and cheap as a diabetic's blood sugar tests to diagnose a range of diseases
'It could be that these trigger settings in the embryo that affect the risk of obesity or diabetes in life.'
diabetes and inflammatory bowel disorders can arise by the targeted acceleration or deceleration of secreted protein aging and turnover."
"It has been known that circulating glycosidase enzyme levels are altered in diseases such as sepsis, diabetes, cancer and various inflammatory conditions.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011